Cargando…

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA

SIMPLE SUMMARY: In recent years, the genetic landscape of hepatocellular carcinoma (HCC) has been explored, identifying TERT promoter, CTNNB1, and TP53 as the most frequent mutated genes. Therapies directed against specific targetable genomic alterations are the basis of personalized medicine and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campani, Claudia, Zucman-Rossi, Jessica, Nault, Jean-Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913369/ https://www.ncbi.nlm.nih.gov/pubmed/36765775 http://dx.doi.org/10.3390/cancers15030817

Ejemplares similares

Molecular Classification of Hepatocellular Adenomas
por: Nault, Jean Charles, et al.
Publicado: (2013)

Genomics of Viral Hepatitis-Associated Liver Tumors
por: Péneau, Camille, et al.
Publicado: (2021)

The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma
por: Ahn, Sung-Min, et al.
Publicado: (2018)

Molecular Determinants of Prognosis in Hepatocellular Carcinoma
por: Nault, Jean-Charles
Publicado: (2014)

Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma
por: Ilboudo, Adeodat, et al.
Publicado: (2014)

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
por: Nault, Jean Charles, et al.
Publicado: (2013)

Corrigendum: High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
por: Charles Nault, Jean, et al.
Publicado: (2013)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
por: Amaddeo, Giuliana, et al.
Publicado: (2015)

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas
por: Dhayat, Sameer A., et al.
Publicado: (2020)

Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002–2022)
por: Sidali, Sabrina, et al.
Publicado: (2023)

The transcriptomic G1–G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion
por: Allen, John Carson, et al.
Publicado: (2016)

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
por: Péneau, Camille, et al.
Publicado: (2022)

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
por: Nahon, Pierre, et al.
Publicado: (2020)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

Hepatocellular adenoma: what is new in 2008
por: Bioulac-Sage, Paulette, et al.
Publicado: (2008)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma
por: Lyu, Xueying, et al.
Publicado: (2022)

New concepts in the treatment of hepatocellular carcinoma
por: Sidali, Sabrina, et al.
Publicado: (2022)

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
por: Pilati, Camilla, et al.
Publicado: (2011)

Circulating Tumor Cells Measurements in Hepatocellular Carcinoma
por: Chiappini, Franck
Publicado: (2012)

Research progress on circulating tumor cells of hepatocellular carcinoma
por: Wan, Chenyu, et al.
Publicado: (2021)

Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma
por: von Felden, Johann, et al.
Publicado: (2018)

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
por: Wu, Xiaolin, et al.
Publicado: (2020)

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
por: Wang, Jian, et al.
Publicado: (2020)

Molecular classification of hepatocellular adenomas: impact on clinical practice
por: Védie, Anne-Laure, et al.
Publicado: (2018)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner
por: Campani, Claudia, et al.
Publicado: (2020)

Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation
por: Hocquelet, Arnaud, et al.
Publicado: (2016)

New insights in the management of Hepatocellular Adenoma
por: Klompenhouwer, Anne J., et al.
Publicado: (2020)

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
por: Schulze, Kornelius, et al.
Publicado: (2015)

Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma
por: Salehi, Mahsa, et al.
Publicado: (2023)

Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
por: Espejo-Cruz, María Lola, et al.
Publicado: (2021)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Brandt, Anna, et al.
Publicado: (2023)

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
por: Bayard, Quentin, et al.
Publicado: (2018)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma
por: Jiang, Peiyong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0tc8amij5jaffbrccql5lcb0hh